Clinical Trial Update: Study of Eque-cel CAR-T Therapy in Newly Diagnosed Severe AL Amyloidosis [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study of Eque-cel CAR-T therapy for newly diagnosed severe AL amyloidosis, which is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Al Amyloidosis

Drugs mentioned

• Eque-cel CAR-T Therapy

Snippet

Sponsor: Nanjing IASO Biotechnology Co., Ltd. | Conditions: AL Amyloidosis | Phase 2 | Status: NOT_YET_RECRUITING